[
  {
    "ts": null,
    "headline": "How Analyst Views Are Shaping Eli Lilly’s Evolving Growth Story",
    "summary": "Eli Lilly’s stock has recently seen its consensus analyst price target rise from $1,003 to $1,024. This change reflects growing optimism among investors and follows fresh analyst reports and updated financial models, which are influenced by new product launches and expanding drug coverage. Stay tuned to discover how you can track these evolving perspectives and remain informed about future changes in Eli Lilly’s investment narrative. Stay updated as the Fair Value for Eli Lilly shifts by...",
    "url": "https://finnhub.io/api/news?id=3b00804926cb065870d447075a1a1011cbc0d96feff7c5c21d6e4ef2f8e5c57c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764580215,
      "headline": "How Analyst Views Are Shaping Eli Lilly’s Evolving Growth Story",
      "id": 137650521,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TFC",
      "source": "Yahoo",
      "summary": "Eli Lilly’s stock has recently seen its consensus analyst price target rise from $1,003 to $1,024. This change reflects growing optimism among investors and follows fresh analyst reports and updated financial models, which are influenced by new product launches and expanding drug coverage. Stay tuned to discover how you can track these evolving perspectives and remain informed about future changes in Eli Lilly’s investment narrative. Stay updated as the Fair Value for Eli Lilly shifts by...",
      "url": "https://finnhub.io/api/news?id=3b00804926cb065870d447075a1a1011cbc0d96feff7c5c21d6e4ef2f8e5c57c"
    }
  }
]